Date:
2025-04-25
McCormick Place Convention Center Chicago, IL
Title: Developing Multi-Modal MRD and ctDNA Tests for Use
in Clinical Research: Droplet Digital PCR-Driven Mutation and
Methylation Quantification, CTCs and Proteomics
Speakers:
- Howard I. Scher, MD
Genitourinary Medical Oncologist and
Head of the Biomarker Development Program
Memorial Sloan Kettering Cancer Center - Gary Pestano, PhD
Chief Development Officer and
NYS CLEP Laboratory Director
Biodesix - Paul van Der Leest, PhD
Postdoctoral Fellow
The Netherlands Cancer Institute
Date: Monday, April 28th, 2025
Time: 12:30 PM
Location: Spotlight Theater A
Join us at booth 2808 to explore the latest innovations in:
- Ultra-sensitive, highly multiplexed ddPCR assays for ctDNA analysis
- Including ESR1, MSI, PIK3CA, methylation analysis, and more
- Circulating tumor cell (CTC) isolation and characterization by downstream genomic analysis
- Rapid and sensitive assessment of oncology-specific protein biomarkers
- Cost-effective, user-friendly gene expression analysis
- Flexible, high-resolution immunophenotyping panels
Have a specialist contact me
Required fields